Article
Implementing and scaling up HCV treatment services for people who inject drugs and other high risk groups in Ukraine: An evaluation of programmatic and treatment outcomes.
The International journal on drug policy - 1 Sept 2017
Mazhnaya Alyona, Meteliuk Anna, Barnard Tetiana, Zelenev Alexei, Filippovych Sergii, Altice Frederick L
Abstract excerpt
BACKGROUND: HCV prevalence estimates among people who inject drugs (PWID) in Ukraine is high (60-90%), yet barriers to HCV treatment and care remain substantial including limited access to direct acting antiviral (DAA) medications. A feasibility scale-up project implemented HCV treatment in community-based settings to improve access to DAA treatment for key populations in this context. METHODS: Using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
